Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10881696
Network-based microbial compositions and methods
granted -
US 10881691
Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
granted -
US 10881669
Inhibitors of the plasmodial surface anion channel as antimalarials
granted -
US 10881666
Combination pharmaceutical agents as RSV inhibitors
granted -
US 10881660
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
granted -
US 10881653
Tricyclic compounds and their use in the treatment of cancer
granted -
US 10881086
Genetically modified mouse whose genome comprises a humanized CD274 gene
granted -
US 10881658
Methods for treating Huntington's disease
granted -
US 10881630
Creatine oral supplementation using creatine hydrochloride salt
granted -
US 10883994
Identification of cancer stem cells markers and use of same for diagnosis and treatment
granted -
US 10881104
Arthropod control composition, formulation, and method
granted -
US 10876116
Anti-ARID3a treatments for inflammatory disorders
granted -
US 10878964
Predictive control model for the artificial pancreas using past predictions
granted -
US 10876134
Gene therapy for juvenile batten disease
granted -
US 10876123
Chimeric antigen receptors targeting B-cell maturation antigen
granted -
US 10876119
Reduced size self-delivering RNAI compounds
granted -
US 10876114
Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 50-53
granted -
US 10875915
Anti-CXCR5 antibodies and compositions and uses thereof
granted -
US 10876003
Class of stable heptamethine cyanine fluorophores and biomedical applications thereof
granted -
US 10875912
EGFL6 specific monoclonal antibodies and methods of their use
granted -
US 10875893
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
granted -
US 10875903
Bifunctional fusion proteins to inhibit angiogenesis in tumor microenvironment and to activate adaptive immune responses and the genes and uses thereof
granted -
US 10875860
Azaindenoisoquinoline compounds and uses thereof
granted -
US 10875885
β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted purine nucleotides for HCV treatment
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.